Ventureast Drug Discovery Services Profile
Key Indicators
- Authorised Capital ₹ 0.75 M
as on 01-07-2024
- Paid Up Capital ₹ 0.75 M
as on 01-07-2024
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2020)
- Profit -495110.40%
(FY 2020)
- Ebitda -495019.23%
(FY 2020)
- Net Worth -100.25%
(FY 2020)
- Total Assets -99.98%
(FY 2020)
About Ventureast Drug Discovery Services
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.75 M and a paid-up capital of Rs 0.75 M, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Alur and Vishnu Kamalapuri serve as directors at the Company.
- CIN/LLPIN
U24297TG2006PTC050815
- Company No.
050815
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Aug 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ventureast Drug Discovery Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Alur  | Director | 04-Aug-2006 | Current |
| Vishnu Kamalapuri | Director | 28-Jun-2015 | Current |
Financial Performance of Ventureast Drug Discovery Services.
Ventureast Drug Discovery Services Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 495110.4% decrease in profit. The company's net worth observed a substantial decline by a decrease of 100.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ventureast Drug Discovery Services?
In 2019, Ventureast Drug Discovery Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ventureast Fund Advisors (India) Private LimitedActive 23 years 3 monthsRamesh Alur is a mutual person
- Ventureast Social Investment Trustee Private LimitedActive 17 years 5 days
Vishnu Kamalapuri is a mutual person
- Ventureast Micro-Equity Managers Private LimitedActive 17 years 2 months
Vishnu Kamalapuri is a mutual person
- Ventureast Investment Advisors Private LimitedActive 8 years 7 months
Vishnu Kamalapuri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ventureast Drug Discovery Services?
Unlock and access historical data on people associated with Ventureast Drug Discovery Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ventureast Drug Discovery Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ventureast Drug Discovery Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
